- Tytuł:
- Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.
- Autorzy:
- Źródło:
- Nature communications [Nat Commun] 2024 Mar 05; Vol. 15 (1), pp. 1985. Date of Electronic Publication: 2024 Mar 05.
- Typ publikacji:
- Clinical Trial, Phase II; Journal Article
- MeSH Terms:
-
Ovarian Neoplasms*/drug therapy
Antineoplastic Combined Chemotherapy Protocols */adverse effects
Female ; Humans ; Antibodies, Monoclonal ; Bevacizumab/therapeutic use ; Carcinoma, Ovarian Epithelial ; Chronic Disease ; Phthalazines ; Piperazines ; Platinum ; Recurrence
Czasopismo naukowe